Generic Drug Market Projected to Reach $615.72 Billion by 2030, Growing at a 5.22% CAGR: Stellar Market Research

𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐆𝐫𝐨𝐰𝐭𝐡:

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 size was valued at USD 431.15 Bn. in 2023 and the total Global Generic Drug Market revenue is expected to grow at a CAGR of 5.22% from 2024 to 2030, reaching nearly USD 615.72 Bn. in 2030.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Generic drugs are designed to be identical to brand-name drugs in terms of dosage form, safety, strength, administration method, quality, performance, and intended use. They contain the same active ingredients and offer the same therapeutic benefits as their brand-name counterparts. Typically, generic drugs are significantly cheaper, often costing 80-85% less than brand-name drugs. The FDA ensures that generic medications meet the same rigorous manufacturing and quality standards as branded drugs.

𝐔𝐧𝐥𝐨𝐜𝐤 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐎𝐮𝐫 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰:https://www.stellarmr.com/report/req_sample/Generic-Drug-Market/1638

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬?

1. Rising Prevalence of Chronic Diseases: The growing incidence of chronic conditions such as diabetes and cardiovascular disorders is a major driver for the generic drug market. As these diseases become more common, there is an increased demand for affordable treatment options. Generic drugs offer cost-effective alternatives to brand-name medications, making them more attractive to both patients and healthcare providers. With the expiration of patents on brand-name drugs, generic alternatives become available, further enhancing accessibility and affordability.

2. Cost Effectiveness: Cost-effectiveness is a primary factor driving the generic drug market. Generic drugs are generally less expensive because they do not require the same level of research and development as brand-name drugs. The lower cost of production and reduced marketing expenses contribute to their affordability. For example, Lisinopril, a drug for high blood pressure, is available as a generic (lisinopril hydrochloride) at a fraction of the cost of its brand-name counterpart. A month's supply of lisinopril tablets (20 mg) costs approximately $30, while the generic version is around $10.

3. Patent Expiries and Generic Competition: The expiration of patents on brand-name drugs creates opportunities for generic manufacturers to enter the market. The introduction of generic drugs leads to increased competition and reduced prices for medications, benefiting patients and healthcare systems. This competitive environment encourages further adoption of generics.

4. Increasing Application of Robotic Process Automation (RPA): The use of Robotic Process Automation in the pharmaceutical industry helps streamline operations, reduce costs, and improve efficiency in the production of generic drugs. This technological advancement supports market growth by making the production process more cost-effective and reliable.

Market Restraints
1. High Barriers for New Entrants: Entering the generic drug market can be challenging due to high barriers such as regulatory hurdles, significant capital requirements, and established competition. New entrants must navigate complex approval processes and demonstrate their ability to meet stringent quality standards.

2. Stringent Regulations: The generic drug industry is subject to strict regulatory requirements to ensure drug safety and efficacy. Compliance with these regulations can be time-consuming and costly, posing challenges for market participants.

3. Consolidation of Suppliers: Consolidation among pharmaceutical suppliers can limit the availability of raw materials and increase production costs. This consolidation may impact the ability of generic drug manufacturers to source necessary components efficiently.

4. Limited Access to Information and Low Transparency: The lack of transparency in drug pricing and limited access to information about generic drugs can hinder market growth. Patients and healthcare providers may face difficulties in understanding the cost advantages and availability of generics.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 ?

North America- United States, Canada, and Mexico

Europe - UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe

Asia Pacific - China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa

South America - Brazil, Argentina, Rest of South America

𝐅𝐑𝐄𝐄 𝐆𝐞𝐭 𝐚 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰! @https://www.stellarmr.com/report/req_sample/Generic-Drug-Market/1638

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 ?

By Type

Simple Generics
Super Generics
Biosimilars
By Brand

Pure Generics
Branded Generics
By End-User

Hospitals
Homecare
Speciality Clinics
Others

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

Teva Pharmaceutical Industries Ltd.
Novartis AG (Sandoz International)
Viatris
Sun Pharma
Fresenius Kabi
Aurobindo Pharma
Mylan N.V.
Pfizer Inc.
Sanofi
Novel Understanding
Fresenius SE & Co.
Lupin Limited
Endo Pharmaceuticals Inc.
Aspen Pharmacare Holdings Limited
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Cipla Ltd.
Alkem Laboratories
Cadila Healthcare Ltd.
Intas Pharmaceuticals Ltd.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐥𝐞𝐚𝐬𝐞 𝐕𝐢𝐬𝐢𝐭:https://www.stellarmr.com/report/Generic-Drug-Market/1638

𝐊𝐞𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬:

Past Market Size and Competitive Landscape
Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Vinyl Flooring Market https://www.stellarmr.com/report/Vinyl-Flooring-Market/1109

Marine Propellers Market https://www.stellarmr.com/report/Marine-Propellers-Market/1128

Vegan Cosmetics Market https://www.stellarmr.com/report/Vegan-Cosmetics-Market/1129

Andalusite Market https://www.stellarmr.com/report/Andalusite-Market/1135

Automotive Seat Heater Market https://www.stellarmr.com/report/Automotive-Seat-Heater-Market/1137

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

S.no.8, h.no. 4-8 Pl.7/4 Kothrud

Pinnac Memories Fl. No. 3

Kothrud, Pune, Maharashtra, 411029

sales@stellarmr.com

+91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Stellar Market Research is an India-based consulting and advisory firm focused on helping clients reach their business transformation objectives with advisory services and strategic business. Firm research on many topics like Healthcare, Pharmaceuticals, Electronics and communications, Chemical and Material, Food and Beverages, Aerospace and defense, and other sectors. The company provide numerous services i.e. consultancy, Market Intelligence, Syndicate Research etc. to help executives in any organization and consumers achieve their mission-critical goals.

This release was published on openPR.